Celecoxib, rofecoxib, and acute temporary visual impairment

Another wonderful example of how little we know of human physiology. Basically, we don’t fully begin to grasp the complexity of an enzyme until we begin shutting it down on a grand scale; i.e. FDA approval. We thought we knew what cyclo-oxygenase 2 did until we released the new wonder arthritis drugs Celebrex and Vioxx. Now we are seeing that COX-2 is essential for heart health, bone formation and now maybe some visual impacts as well. Coulter et al. 327 (7425): 1214.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.